Tuesday, June 21, 2016

BRIEF-Eli Lilly Canada says Health Canada approves Taltz for treatment of moderate-to-severe plaque psoriasis

* Eli Lilly Canada says Health Canada has granted approval

for Taltz for treatment of moderate-to-severe plaque psoriasis

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom; +1 646 223 8780; )

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)